1(2H)-Pyridinecarboxamide, 4-[6-amino-7-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]furo[3,2-c]pyridin-3-yl]-3,6-dihydro- manufacturers
- OSI-296
-
- $3400.00
-
2026-07-27
- CAS:1175296-94-2
- Purity:
- Supply Ability: 10g
|
| | 1(2H)-Pyridinecarboxamide, 4-[6-amino-7-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]furo[3,2-c]pyridin-3-yl]-3,6-dihydro- Basic information |
| | 1(2H)-Pyridinecarboxamide, 4-[6-amino-7-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]furo[3,2-c]pyridin-3-yl]-3,6-dihydro- Chemical Properties |
| Boiling point | 633.0±65.0 °C(Predicted) | | density | 1.482±0.06 g/cm3(Predicted) | | pka | 14.55±0.40(Predicted) |
| | 1(2H)-Pyridinecarboxamide, 4-[6-amino-7-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]furo[3,2-c]pyridin-3-yl]-3,6-dihydro- Usage And Synthesis |
| Description | OSI-296 is a potent and dual inhibitor of cMET and RON kinases with IC50 for cMet = 42 nM and IC50 for sfRon = 200 nM. OSI-206 shows in vivo efficacy in tumor xenografts models upon oral dosing and is well tolerated. OSI-296 also reduced tumour growth in the bone. | | Uses | OSI-296 is a potent, oral and selective inhibitor of cMET and RON kinases. OSI-296 shows in vivo efficacy in MKN45 tumor xenografts models and well tolerated[1]. | | References | [1] Steinig AG, et al. Novel 6-aminofuro[3,2-c]pyridines as potent, orally efficacious inhibitors of cMET and RON kinases. Bioorg Med Chem Lett. 2013;23(15):4381-4387. DOI:10.1016/j.bmcl.2013.05.074 |
| | 1(2H)-Pyridinecarboxamide, 4-[6-amino-7-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]furo[3,2-c]pyridin-3-yl]-3,6-dihydro- Preparation Products And Raw materials |
|